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Artificial gait in complete spinal cord injured
subjects: how to assess clinical performance
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clínico
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Barreto Martins4, Alberto Cliquet-Jr1,5
ABSTRACT
Objective: Adapt the 6 minutes walking test (6MWT) to artificial gait in complete spinal cord injured (SCI) patients aided by neuromuscular
electrical stimulation. Method: Nine male individuals with paraplegia (AIS A) participated in this study. Lesion levels varied between T4 and
T12 and time post injured from 4 to 13 years. Patients performed 6MWT 1 and 6MWT 2. They used neuromuscular electrical stimulation,
and were aided by a walker. The differences between two 6MWT were assessed by using a paired t test. Multiple r-squared was also
calculated. Results: The 6MWT 1 and 6MWT 2 were not statistically different for heart rate, distance, mean speed and blood pressure.
Multiple r-squared (r2 = 0.96) explained 96% of the variation in the distance walked. Conclusion: The use of 6MWT in artificial gait towards
assessing exercise walking capacity is reproducible and easy to apply. It can be used to assess SCI artificial gait clinical performance.
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RESUMO
Objetivo: Adaptar o teste de caminhada dos 6 minutos (TC6) para marcha artificial de pacientes com lesão medular completa associado a
eletroestimulação neuromuscular. Método: Nove participantes do sexo masculino com paraplegia (AIS A) participaram do estudo. O nível
de lesão variou entre T4 e T12 , tempo de lesão variou entre 4 e 13 anos. Os pacientes realizaram dois TC6 (TC6-1 e TC6-2). Os
participantes usaram eletroestimulação neuromuscular e foram auxiliados por andador. As diferenças entre os dois TC6 foram avaliadas
pelo teste t pareado e calculado o r2. Resultados: Não foi encontrada diferença estatística entre TC6-1 e TC6-2 para frequência cardíaca,
distância, velocidade média e pressão arterial. O r2 = 0,96 explica 96% da variação na distância caminhada. Conclusão: O uso do TC6 em
marcha artificial para avaliação da capacidade de exercício de caminhada é reprodutível e fácil de aplicar. Esse teste pode ser utilizado
para avaliar o desempenho clínico da marcha artificial de indivíduos com lesão medular.
Palavras-chave: lesão medular, marcha, reabilitação, paraplegia.
Assessing walking in patients with locomotion disorders
is an important measure in rehabilitation. However, the
walking ability of spinal cord injured (SCI) subjects ranges
from total incapacity to near normal speed1, due to the large
variability of lesion.
Many methods were developed to allow gait of spinal
cord injured subjects, including a variety of orthosis, neuro-
muscular electrical stimulation (NMES), hybrid orthosis2 and
exoskeleton3. Without walking aiding devices, complete SCI
subjects are limited to the wheelchair, which is practical
towards locomotion. One gait training option is the asso-
ciation with NMES, even quadriplegic patients are able to
walk aided by body-weight support tool and NMES4.
Since 1989, our laboratory has been developing techno-
logy to prepare subjects with spinal cord injury to walk again
using NMES. Studies showed benefits of this gait training as
increase in bone mass, the preservation of join integrity and
cardiovascular improvement4,5,6.
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As the artificial gait has demonstrated good results, clin-
ical research is necessary to assess the evolution of such
therapy. Some authors have developed ways to assess SCI
walking. Walking index for spinal cord injury (WISCI) was
validated7 and revised later into the WISCI II8. Timed walk-
ing tests like the Time Up and Go (TUG) test, the 10-meter
walk test, were developed and adapted to assess SCI
patients9. The physiological cost index (PCI) is widely
used10, however heart rate steady state is necessary and
it is not always obtained. The total heart beat index
could also be an alternative method to represent energy
expenditure11.
The 6-minute walk test (6MWT) that measures the
walked distance (in meters) during 6 minutes was first vali-
dated for SCI by Hedel et al.9. This test evaluates the system
responses involved in exercise which include pulmonary and
cardiovascular systems, neuromuscular units, muscle meta-
bolism and assesses the submaximal level of functional
capacity (relevant for daily activities)12.
The 6MWT is used with success in pretreatment and
post treatment comparisons, as functional status, and can
predict morbidity and mortality12. Recently the 6MWT has
been implemented to incomplete patients with SCI9,13,14. As
6MWT has been used to assess incomplete SCI subjects,
the purpose of the current investigation was to adapt the
6MWT to assess complete SCI patients aided by NMES once
the artificial gait was introduce recently as a therapy and
now its importance increased not only of walking level,
but also of walking performance.
The aim of the current investigation was to assess the
artificial gait by 6 minute walking test (6MWT) adapted to




Nine male individuals with paraplegia (AIS A) partici-
pated in this study. Lesion levels varied between T4 and
T12 and time post injured from 4 to 13 years.
The mean age was 32.78 ± 11.58 years old, height
180 ± 0.05 cm, mass 74.33 ± 8.69 kg and 7.76 ± 3.18 years’
post-injury.
At the time of the study, the subjects were all in a clinically
stable state and none of them complained of respiratory
symptoms or related history of cardiopulmonary disease.
Subjects were selected among patients who were admit-
ted in the ambulatory clinic, Hospital Universitário da
Universidade Estadual de Campinas. Important criteria for
inclusion in the study were the walking ability using
NMES and the use of ankle foot orthosis (AFO). All of them
had sessions of gait training before tests.
State University of Campinas’s Ethics Committee
approval was obtained for this study protocol. Before tests,
the procedures were described in detail and consent was
obtained from all subjects.
Experimental protocol
Six-Minute walk test
The 6-min walk test was conducted according to the stan-
dardized protocol12 and it was adapted to paraplegic patients.
Subjects were instructed to walk in a hospital corridor and
they were instructed to walk as fast as possible during 6 min-
utes. Physical therapists encouraged subjects with standar-
dized statements12, i.e., use an even tone of voice when
using the standard phrases of encouragement. They were
allowed to stop and rest any time they needed, but were
instructed to return walking as soon as they felt able.
All of them had their quadriceps and fibular nerve stimu-
lated with neuromuscular electrical stimulation (NMES): a
4-channel electrical stimulator delivered a signal of 25 Hz
with monophasic rectangular pulses with 300 ms duration
and a maximum intensity of 200 V (1 KV load).
The patients performed two tests (6MWT 1 and 6MWT 2)
in the same period of day in two different days (interval of
one week). They used an AFO and were aided by walker.
Heart rate was collected beat-to-beat (S810, Polar1, Oulu,
Finland); distance and test time were measured.
Before the artificial gait, the participants were involved in a
protocol to avoid fatigue that was shared in phases: the first
phase was quadriceps training with the participants seated
in their chair and the second one was stand up and sitting
training using NMES and following by keep standing.
Statistical analysis
Data is expressed as mean ± SD with level of significance
set at a = 0.05. The differences between 6MWT 1 and 6MWT 2
were assessed by using a paired t-test. Multiple r-squared was
also calculated.
RESULTS
Table shows the results of heart rate, blood pressure, dis-
tance and speed of 6MWT 1 and 2. The variables were not stat-
istically different. Could be observed that the heart rate range
is 77 bpm, in 6MWT 1 and 78 bpm, in 6MWT 2. The intrarater
reliability of 6-minute walk test was calculated r2 = 0.96 and it
explained 96% of the variation in the distance walked
DISCUSSION
This study demonstrates that 6MWT could be adapted
to SCI patients aided by NMES. Furthermore, the test
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design can assess a large spectrum of complete SCI
subjects.
The comparison of two 6MWT shows that it has good
reproducibility and validity to assess SCI subject functional
capacity, usually it is not necessary apply two tests to assess
the SCI complete subject.
The 6MWT has been used as clinical exercise test to
understand the impact of diseases on physical capacity, like
obstructive lung disease, heart failure12 and even in healthy
adults to reference equations15. The choice of this test was
done due its easily used in the clinical environment and
the standard protocol developed12 that make possible the
test performance by different examinations. It has been used
with success in order to evaluate the gait disorder in incom-
plete SCI subjects9,13,14.
The distance walked varied between patients, it was
always low. These results could be influenced by some fac-
tors. In the literature, when incomplete SCI subjects were
assessed, the mean distances found were 524 m13, 205 m9,
170 m14 and 120 m16, in the present study only one patient
was able to walk 45 m, the others participants walked less
distance. All the subjects had complete SCI lesion and with-
out the NMES they were not able to walk.
Other factor that influences the distance and speed
walked is the kind of aid used. Melis et al.17 showed differ-
ences in speed when SCI subjects walked aided by walker,
crutches or canes. They showed that the gait with walker
is the slowest. However, the best comparison to a patient
is when the subject is compared with himself, because level
of injury, time of rehabilitation and walking aid usually influ-
ence the performance.
Neuromuscular electrical stimulation has became a use-
ful aid to locomotion, however it produces a high energy
cost, which could be observed, in this study, by the large
range found between rest and exercise heart rate and in
the lower distance walked. Jacobs et al.18 comparing the
response of NMES walking in a 10-m test with incremental
peak arm cranking exercise and found a similar peak exer-
cise capacity measured by cardio-respiratory variables. It
suggested that functional electrical stimulation walking
could be also used to endurance conditioning18.
Other benefit of artificial gait is the reduction of spas-
ticity. A study developed in our laboratory demonstrated a
reduction in spasticity after the artificial gait training with
NMES19. Studies about the relationship of spasticity and
walking in SCI subjects usually is focus on spasticity
mechanisms of spasticity20.
Scivoletto et al.21, showed the negative effect of spasticity
in walk performance of SCI subjects. They also included
spasticity as an obstacle to get up, walk and sit down beyond
causes an increase in effort and energy.
However, the principal limitation of NMES is the excess-
ive neuromuscular fatigue22,23. The protocol routine involved
a specific neuromuscular training before the gait, as was
explained above, to avoid the fatigue and increase the parti-
cipants performance. The fatigue and the high energy cost
are the main causes of low performance developed by the
SCI subject.
Many techniques have been developed to improve SCI
patients quality of life. These patients have a large potential
to increase the exercise capacity and consequently, to bene-
fit the muscle skeletal and cardiorespiratory systems.
Therefore, the development and standardize of exercise
assessing are necessary.
The calculation of walking speed over 10 m, is commonly
used in clinical gait assessment, however it may underestim-
ate the SCI subject locomotion capacity. The 10 m test is
very useful in the beginning of training, specially, due the
fatigue caused by NMES and high energy cost. Following
the training, the 6MWT showed capable of evaluating the
physical and locomotion capacity more completely and in
a very simple way.
In conclusion, the artificial gait has been improved and it
has been introduced in ambulatory therapy with success.
Consequently, to follow these patients progress tests need
to be adapted. The use of 6MWT to assess the exercise walk-
ing capacity of complete spinal cord injury paraplegics is
promising. The reproducibility of the test and its easy
application are positive points.
The results suggest that 6MWT could be included in
rehabilitation programmes as a clinical assessment tool for
paraplegic patients and it yields many information about
the therapy and its evolution.
New studies are necessary to observe others aspects of
SCI artificial gait such as balance and the influence of stand
up and sit down in the gait.
Table. Results of 6MWT.
Variable 6MWT 1 6MWT 2
HR rest (bpm) 78.00 ± 8.75 79.00 ± 7.06
HR peak (bpm) 155.00 ± 15.06 157.00 ± 14.68
Distance (m) 21.13 ± 11.76 20.78 ± 11.84
Mean speed (m/s) 0.07 ± 0.24 0.07 ± 0.25
SBP in rest (mmHg) 115.56 ± 8.82 114.44 ± 5.27
DBP rest (mmHg) 76.67 ± 7.07 73.33 ± 7.07
SBP exercise (mmHg) 137.78 ± 24.38 138.33 ± 23.58
DBP exercise (mmHg) 75.56 ± 8.82 76.67 ± 8.29
*p , 0.05 to compare 6MWT 1 and 2; values were in mean ± SD. 6MWT: 6
minute walking test; HR: Heart rate; SBP: Systolic blood pressure; DBP:
Diastolic blood pressure.
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